CVE-2008-1006

Description

Cross-site scripting (XSS) vulnerability in WebCore, as used in Apple Safari before 3.1, allows remote attackers to inject arbitrary web script or HTML by using the window.open function to change the security context of a web page.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.98% Top 25%
Vendor Advisory apple.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/bid/28332 vdb entry
http://www.securitytracker.com/id?1019653 vdb entry
http://www.us-cert.gov/cas/techalerts/TA08-079A.html third party advisory us government resource
http://lists.apple.com/archives/security-announce/2008/Mar/msg00000.html patch vendor advisory
http://www.securityfocus.com/bid/28290 vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/41326 vdb entry
http://docs.info.apple.com/article.html?artnum=307563
http://www.vupen.com/english/advisories/2008/0920/references vdb entry
http://secunia.com/advisories/29393 third party advisory

Frequently Asked Questions

What is the severity of CVE-2008-1006?
CVE-2008-1006 has been scored as a medium severity vulnerability.
How to fix CVE-2008-1006?
To fix CVE-2008-1006, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-1006 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2008-1006 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.